61. Multiple Myeloma Treatments At Greenebaum Cancer Center The University of Maryland Greenebaum Cancer Center offers an innovativeapproach to treating multiple myeloma. (top). What is multiple myeloma? http://www.umm.edu/cancer/canc_multmyel.html

Greenebaum Cancer Center About GCC... Clinical Trials... Cancer Overviews ... GCC News Outside UMM International Myeloma Foundation Multiple Myeloma Research Foundation Greenebaum Cancer Center Multiple Myeloma Treatments at the University of Maryland Greenebaum Cancer Center The University of Maryland Greenebaum Cancer Center offers an innovative approach to treating multiple myeloma Overview Stem Cell Transplantation What is multiple myeloma? Coping ... Glossary Overview The University of Maryland Greenebaum Cancer Center is setting the standard for a new approach to stem cell transplantation to fight multiple myeloma and similar cancers. Instead of giving low doses of chemotherapy, the Greenebaum Cancer Center advocates giving high-dose chemotherapy with stem cell transplantation early in the course of some cancers. This new approach aims to fight cancer cell resistance to chemotherapy. High-dose chemotherapy lowers the chances of myeloma cells escaping and becoming resistant to treatment. Stem cell transplantation and high-dose therapy should be done early in the disease when myeloma cells are still sensitive to chemotherapy and when the bone marrow has not been damaged by conventional chemotherapy. To maximize the chances of controlling multiple myeloma as long as possible, the University of Maryland Greenebaum Cancer Center gives patients further treatments after their transplantation every three months for one year. There is preliminary evidence that these further treatments increase survival.

62. Macroglobulinemia multiple myeloma Myeloma. Plasmacytoma. Hematology and Oncology multiple myeloma Marrow,Hematology and Oncology multiple myeloma Marrow. (Click image to enlarge). http://www.fpnotebook.com/HEM134.htm

Home About Links Index ... Editor's Choice Paid Advertisement (click above). Please see the privacy statement Hematology and Oncology Marrow Anemia ... Fanconi Anemia Assorted Pages Macroglobulinemia Multiple Myeloma Myelofibrosis Polycythemia Rubra Vera ... Bone Marrow Aspiration Macroglobulinemia Waldenstrom's Macroglobulinemia Primary Macroglobulinemia Book Home Page Cardiovascular Medicine Dental Dermatology Emergency Medicine Endocrinology Gastroenterology General Medicine Geriatric Medicine Gynecology Hematology and Oncology HIV Infectious Disease Jokes Laboratory Neonatology Nephrology Neurology Obstetrics Ophthalmology Orthopedics Otolaryngology Pediatrics Pharmacology Prevention Psychiatry Pulmonology Radiology Rheumatology Sports Medicine Surgery Urology Chapter Hematology and Oncology Index Anemia Cancer Coagulopathy Cardiovascular Medicine Dermatology Endocrinology Otolaryngology Examination Gastroenterology Hematology and Oncology Hemoglobin Hemolysis Histiocytosis HIV Infectious Disease Laboratory Leukemia General Pulmonology Lymph Marrow Neurology Obstetrics Orthopedics Pediatrics Pharmacology Platelet Prevention Procedure Psychiatry Rheumatology Surgery Symptom Evaluation Vascular Page Marrow Index Anemia Aplastic Anemia Fanconi Macroglobulinemia Multiple Myeloma Myelofibrosis Polycythemia Pathophysiology Lymphoproliferative Malignancy Proliferation of plasma cells and Lymphocyte s Similar to Multiple Myeloma Produces a large monoclonal IgM protein Epidemiology Older men more frequently affected Hereditary component Symptoms Weakness Fatigue Oronasal bleeding

63. BestDoctors.com: Condition Summary: Multiple Myeloma multiple myeloma is a cancer of a certain type of white blood cellcalled the plasma cell. The plasma multiple myeloma. William S http://www.bestdoctors.com/en/conditions/m/myeloma/myeloma_092900.htm

Site Map Language English Spanish Select A Language Search Condition Summaries Doctor Is In™ William S. Dalton, M.D. Articles by Dr. Dalton Multiple Myeloma Multiple Myeloma William S. Dalton, M.D. Clinical Investigations, H. Lee Moffitt Cancer Center, Tampa, FL Oncology, Pharmacology and Biochemistry, University of South Florida, Tampa, FL What is myeloma? Multiple myeloma is a cancer of a certain type of white blood cell called the plasma cell. The plasma cell is born and normally resides in the bone marrow. The normal function of the plasma cell is to produce antibodies that fight infections and possibly even other cancers. Although all normal plasma cells appear similar, each plasma cell is uniquely programmed to produce a single type of antibody called a monoclonal antibody. Myeloma arises in the bone marrow of patients when a single cell or clone of plasma cells begins to grow uncontrollably and produce an overabundance of one type of antibody or monoclonal antibody. In this situation, instead of many different plasma cells producing a normal array of different antibodies, the patient's immune system overproduces a single type of antibody and not enough of the other type of antibodies. The major clinical manifestations of myeloma involve frequent infections, bone pain, fatigue due to anemia and kidney damage.

64. Myeloma Cancer Information - National Foundation For Cancer Research multiple myeloma research, prevention, treatment at a glance. Approximate AnnualEstimates for new cases (US) 13,000. Help find a cure for multiple myeloma. http://www.nfcr.org/site/PageServer?pagename=cancers_myeloma

65. Hematopathology The skull demonstrates the characteristic rounded punched out lesions of multiple myeloma. http://medlib.med.utah.edu/WebPath/HEMEHTML/HEME039.html

The skull demonstrates the characteristic rounded "punched out" lesions of multiple myeloma.

66. EMedicine - Multiple Myeloma : Article By Steven M Sorenson, MD multiple myeloma multiple myeloma is the most common primary neoplasm of the skeletalsystem. The disease is a malignancy of plasma cells. multiple myeloma. http://www.emedicine.com/radio/topic460.htm

(advertisement) Home Specialties CME PDA ... Patient Education Articles Images CME Patient Education Advanced Search Link to this site Back to: eMedicine Specialties Radiology Musculoskeletal Multiple Myeloma Last Updated: December 7, 2001 Rate this Article Email to a Colleague Synonyms and related keywords: plasma cell myeloma, myeloma AUTHOR INFORMATION Section 1 of 12 Author Information Introduction Differentials X-ray ... Bibliography Author: Steven M Sorenson, MD , Staff Physician, Department of Radiology, University of California at San Diego Medical Center Coauthor(s): Amilcare Gentili, MD , Associate Professor of Radiology, University of California at Los Angeles; Assistant Chief, Department of Radiology, West Los Angeles Veterans Affairs Medical Center Sulabha Masih, MD , Associate Professor of Diagnostic Radiology, University of California at Los Angeles; Consulting Staff, Department of Radiology, Section of Musculoskeletal Radiology, West Los Angeles Veterans Affairs Medical Center Carol Andrews, MD , Director, Spinal Injection Service, Assistant Professor, Department of Radiology, Section of Musculoskeletal Radiology, University of California at Los Angeles School of Medicine Steven M Sorenson, MD, is a member of the following medical societies:

67. EMedicine - Multiple Myeloma : Article By Sara Grethlein, MD multiple myeloma multiple myeloma is a debilitating malignancy that is partof a spectrum of diseases ranging from monoclonal gammopathy of unknown http://www.emedicine.com/MED/topic1521.htm

(advertisement) Home Specialties CME PDA ... Patient Education Articles Images CME Patient Education Advanced Search Link to this site Back to: eMedicine Specialties Medicine, Ob/Gyn, Psychiatry, and Surgery Hematology Multiple Myeloma Last Updated: June 12, 2002 Rate this Article Email to a Colleague Synonyms and related keywords: plasma cell myeloma, Kahler's disease, Kahler disease, plasma cell dyscrasia, plasma cell leukemia, leukopenia, anemia, thrombocytopenia, bone pain, hypercalcemia, spinal cord compression, hyperviscosity, amyloidosis, renal failure, monoclonal gammopathy of unknown significance, MGUS AUTHOR INFORMATION Section 1 of 11 Author Information Introduction Clinical Differentials ... Bibliography Author: Sara Grethlein, MD , Course Director - Practice of Medicine, Associate Professor, Department of Internal Medicine, Division of Hematology and Oncology, State University of New York at Upstate Sara Grethlein, MD, is a member of the following medical societies: American Society of Hematology Editor(s): Koyamangalath Krishnan, MD, FRCP

68. Atlanta Area Multiple Myeloma Support Group - Home Page Atlanta Area multiple myeloma Support Group. Welcome to the Home Page for theAtlanta Area multiple myeloma Support Group! Site Last Updated 2/1/2003. http://www.mmsg.org/Atlanta/

Home News Web Resources Discussion Group Survivor Profiles Contacts Atlanta Area Multiple Myeloma Support Group "Like a crocus in the snow, I stand knee-deep in Winter, holding Springtime in my heart!" J. Walsh Anglund This website is made possible by an Unrestricted Educational Grant from Novartis Pharmaceutical the makers of Zometa and Aredia Welcome to the Home Page for the Atlanta Area Multiple Myeloma Support Group! Site Last Updated 2/24/2003 Formed in August 1997 by an MM patient who felt that it was essential for both patients and family members to have a network where they could both increase their knowledge about multiple myeloma and support other people going through the same experience, we also agree with research that has shown that cancer patients who participate in a support group do better and survive longer! The International Myeloma Foundation keeps us up to date on treatment information as well as publicizing our group. In addition to funding research into myeloma, The IMF also conducts Patient/Family Seminars worldwide several times each year and publishes a quarterly newsletter, Myeloma Today. If you are a multiple myeloma patient or a concerned family member, one of the first things you should do is contact The IMF to obtain their information package. Use their internet site available through our links page, or call: 1-800-452-CURE.

69. Cancer Control Journal: Table Of Contents Biology of the Transition of Monoclonal Gammopathy of Undetermined Significance (MGUS)to multiple myeloma John A. Lust, MD, PhD, and Kathleen A. Donovan, PhD. http://www.moffitt.usf.edu/pubs/ccj/v5n3/toc.html

May / June 1998 Biology of the Transition of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma John A. Lust, MD, PhD, and Kathleen A. Donovan, PhD Management of Myeloma: Current and Future Approaches Martin M. Oken, MD Interferon in the Treatment of Multiple Myeloma Chaim Shustik, MD, FRCP(C) Hematopoietic Cell Transplantation for Multiple Myeloma William I. Bensinger, MD Guest Editorial: Overview of the Advances in the Treatment of Multiple Myeloma William S. Dalton, PhD, MD Cancer Economics: Contracting With a Medicare HMO Albert B. Einstein, Jr, MD, Patricia J. Goldsmith, and David W. Maberry, MHA Imaging in Oncology: Thallium Imaging of the Brain Claudia G. Berman, MD Ten Best Readings on Multiple Myeloma and Plasma Cell Dyscrasias William S. Dalton, PhD, MD Infections in Oncology: Sternoclavicular Joint Septic Arthritis Ines I. Mbaga, MD, John N. Greene, MD, and Ramon L. Sandin, MD Information for Cancer Patients Special Report: The Generalist Finds a Niche in a Comprehensive Cancer Center A Decade of Growth at the University of Texas M.D. Anderson Cancer Center Carmen P. Escalante, MD; Ellen F. Manzullo, MD; Mary Ann Weiser, MD, PhD; and Edward B Rubenstein, MD Clinical Research Protocols for Multiple Myeloma Calendar of Events In the Next Issue CME Instructions ... Pretest Posttest expired Back to the Cancer Journal Index For comments mail to: ccjournal@moffitt.usf.edu

70. BMT InfoNet Home Page multiple myeloma. International Myeloma Foundation 12650 RiversideDrive Suite 206 North Hollywood CA 91607 phone 800-452-2873 http://www2.bmtnews.org/resource/index.cfm?Fuseaction=ResourceResults&Category=8

71. :: IXth International Workshop On Multiple Myeloma :: abstract submission registration programmes. committees. general informationscientific programme information exhibition. Poster Scientific http://myeloma2003.usal.es/

abstract submission registration programmes abstract submission registration programmes ... Accommodation

72. Multiple Myeloma What is multiple myeloma? multiple myeloma is a cancer of the body'splasma cells. Plasma cells are normally present in the bone http://www.seattlecca.org/patientsandfamilies/adultCare/clinicalProgs/multipleMy

var OPENNODE = '1000,1004,1009,1010,1052,'; var CURRNODE = 1052 init( "setID( CURRNODE );" ); What is multiple myeloma? Multiple myeloma is a cancer of the body's plasma cells. Plasma cells are normally present in the bone marrow (making up less than 5% of the bone marrow) and are responsible for the production of antibodies when the body is dealing with infection. Cancerous plasma cells (myeloma cells) build up in the bone marrow, interfering with normal immune response and bone marrow production of normal blood cells. These myeloma cells invade and damage the bone, causing tumors (myelomas) to form. Myeloma cells then travel to other sites in the body, causing further tumors (hence the name "multiple myeloma"). Common features or symptoms of multiple myeloma are bone pain (especially with movement), anemia, fatigue, hypercalcemia, and increased incidence of infections (such as bladder or kidney infections, skin infections, pneumonia, or sinusitis). Testing for and diagnosis of multiple myeloma normally begins with blood and/or urine tests. These are followed by a direct biopsy to find myeloma cells, or a bone marrow sample showing elevated levels (at least 10%, but usually more than 30%) of plasma cells. Adjunctive diagnostic testing can include whole-body x-ray, to assess for lytic lesions or severe osteoperosis. Multiple Myeloma Treatment Our Services Your Multidisciplinary Team ... Contact Us Related Info Bone Marrow Transplantation at The Seattle Cancer Care Alliance Bone-Marrow and Stem-Cell Transplant Treatment Options at The Seattle Cancer Care Alliance How to Help New treatment Gives Hope to Myeloma Patients ... Site Map Multiple Myeloma

73. Multiple Myeloma Patient Care Services At The SCCA multiple myeloma Patient Care Services at the SCCA. View this article in (PDF) format. Thereis no cure for multiple myeloma with conventional standard therapy. http://www.seattlecca.org/aboutscca/pressRoom/archive/multipleMyelomaarticle.htm

var OPENNODE = '1000,1008,1089,1090,3030,'; var CURRNODE = 3030 init( "setID( CURRNODE );" ); Multiple Myeloma Patient Care Services at the SCCA View this article in (PDF) format Spring 2002 If you have recently diagnosed a patient with multiple myeloma, you know he or she faces a tough battle against a formidable opponent. But the Seattle Cancer Care Alliance (SCCA)'s new approaches to treating the disease offer some promising options and hope for your patient. Patients coming to SCCA gain access to some of the most sophisticated oncology therapies in the world, and will be seen and treated by physicians and researchers who are leading innovative efforts that are proving beneficial to people with multiple myeloma. New Clinic SCCA has recently opened a weekly multiple myeloma clinic to enhance its excellent day-to-day care for people with multiple myeloma. The clinic provides consultation and treatment by physicians from the Fred Hutchinson Cancer Research Center (FHCRC) and the University of Washington Academic Medical Center (UW AMC), world-class research institutions that have pioneered therapies for treating people with a variety of cancers. Every Wednesday, Dr. Scott Schuetze and Dr. William Bensinger, both of the FHCRC and UW AMC, are available to see patients in the multiple myeloma clinic. Working closely with other physicians at SCCA, they provide coordinated patient care and recommendations on a range of therapies, including hematopoietic transplantation, drug therapies and participation in clinical trials.

74. Sloan-Kettering - Multiple Myeloma multiple myeloma is a cancer of the bone marrow that arises when plasma cells white blood cells that produce infectionfighting antibodies become http://www.mskcc.org/mskcc/html/3371.cfm

var tab = tabs[tabs.length] = []; tab.id = 13; var TAB_WWWROOT = "/mskcc/"; var tabDarkColor = "#336699"; var tabMediumColor = "#99BBCC"; createHeaderImageCache(44,512,5626,1072,5664,638,8228); formatTabs(tabs); createNavigationImageCache(457,361,603,6207,474,1979,11984,600,518,539) Cancer Information Types of Cancer Multiple Myeloma Multiple Myeloma Select a Multiple Myeloma Topic Multiple myeloma is a cancer of the bone marrow that arises when plasma cells white blood cells that produce infection-fighting antibodies become malignant and invade the marrow. In this section you can find up-to-date information about multiple myeloma, and learn about Memorial Sloan-Kettering's expertise in caring for patients with this disease. Overview In 2001, about 14,400 people in the United States will be diagnosed with multiple myeloma. The number of new cases diagnosed each year has increased over the past decades, for reasons not well understood. Risk Factors In most cases, patients with multiple myeloma have no known risk factors. Symptoms The symptoms of multiple myeloma most commonly include one or more of the following: bone pain and skeletal fractures; infections; weight loss; hypercalcemia; loss of kidney function; hyperviscosity.

75. Multiple Myeloma Clinical Trials Your Site Location Home / Information for Patients / Clinical Trials.multiple myeloma Clinical Trials. For further information on http://www.dartmouth.edu/dms/nccc/patients/clinical/opentrials/multiple-myeloma.

HOME PATIENTS PROFESSIONALS ABOUT THE CENTER ... Dartmouth Web Search Your Site Location: Home Information for Patients Clinical Trials Multiple Myeloma Clinical Trials For further information on clinical trial eligibility or informed consent call For appointment scheduling call Updated: January, 2003 Affiliation and Number: F 0001 Pharmaceutical-Aventis A Pilot Feasibility Study to evaluate patient recruitment, safety, efficacy, and Compliance for a 180 day period of Enoxaparin alone vs. Enoxaparin followed by Warfarin in the secondary prevention of venous thromboembolism in patients with active malignancy (ENO.US1.402) Affiliation and Number: F 0030 Pharmaceutical- A multi-center randomized Study of Vincristine, Doxil and Dexamethasone versus Vincristine, Doxorubicin, and Dexamethasone in patients with multiple myeloma (C-2000-003-00 ALZA) Affiliation and Number: D 0135 Dartmouth Medical School High dose melphalan followed by autologous peripheral blood stem cell transplantation and immunotherapy for the treatment of multiple myeloma Affiliation and Number: D 9918 Dartmouth Medical School Spouse-assisted coping skills training for management of cancer Clinical Trials All NCCC Clinical Trials Phase I Trials Bone Marrow Transplant Trials Head and Neck Trials ... Pediatric-Protocols In Affiliation with: Dartmouth Medical School Dartmouth-Hitchcock Medical Center The National Cancer Institute The Norris Cotton Cancer Center One Medical Center Drive Lebanon, New Hampshire 03756

76. Multiple Myeloma multiple myeloma. Leukaemia Research Fund produces a booklet on MultipleMyeloma, which provides general information on the disease. http://dspace.dial.pipex.com/lrf-/diseases/myeloma.htm

home patient information multiple myeloma Multiple myeloma Leukaemia Research Fund produces a booklet on Multiple Myeloma, which provides general information on the disease. To download this booklet as a PDF click here . To view a copy of this booklet click here Useful links for health professionals Patient publications on the web Reviews Key information Teaching aids ... Scientific meetings Multiple myeloma is a form of cancer which affects plasma cells in the bone marrow. These are cells which normally produce antibodies. They are a specialised form of B-lymphocyte. The condition is called multiple myeloma because most patients have evidence of disease at a number of different bony sites in the body. Synonyms: Myeloma See also: Plasma Cell Leukaemia Solitary Plasmacytoma Index of available booklets... Adult Acute Lymphoblastic Leukaemia Adult Acute Myeloid Leukaemia Childhood Acute Lymphoblastic Leukaemia Childhood Acute Myeloid Leukaemia Coping With Childhood Leukaemia Amyloidosis Aplastic Anaemia Burkitt's Lymphoma Chronic Lymphocytic Leukaemia Chronic Myeloid Leukaemia Essential Thrombocythaemia Fanconi's Anaemia Hairy Cell Leukaemia Histiocytosis Hodgkin's Disease Immune Thrombocytopaenic Purpura Large Granular Lymphocytic Leukaemia Mast Cell Leukaemia Monoclonal Gammopathy of Unknown Significance

77. Johns Hopkins Kimmel Cancer Center Diagnostic Tests. multiple myeloma is usually diagnosed by a blood test to identifyhigh levels of a type of protein or antibody produced by myeloma cells. http://www.hopkinskimmelcancercenter.org/cancertypes/multiple-myeloma.cfm?cancer

78. Multiple Myeloma Information Cancersource.com offers a wealth of multiple myeloma information including,treatment, symptoms and prevention. multiple myeloma Information. http://www.cancersource.com/20.cfm

Advertisement Multiple Myeloma Information CancerSource.com offers a wealth of multiple myeloma information and resources. Click here to access all the multiple myeloma information features on our site, including disease-specific multiple myeloma information, live chats, news, events, and more. CancerSource.com offers the multiple myeloma information you need to help with early detection and to manage your situation if you have already been diagnosed. Although being diagnosed with multiple myeloma is never easy, patients will find more multiple myeloma information and more treatment choices than ever before. On CancerSource.com, you will find the multiple myeloma information you need to make informed decisions about your health. Below is a list of general multiple myeloma information as well as more specific multiple myeloma information offered by Cancersource.com. General multiple myeloma information includes: Information on support groups News about multiple myeloma Features, events, and resources all related to multiple myeloma information Managing challenges of multiple myeloma Specific information on multiple myeloma includes: Disease-specific multiple myeloma information Multiple myeloma treatment options and possible side effects Information on multiple myeloma symptoms Information on multiple myeloma prevention For more information on multiple myeloma

79. Multiple Myeloma CancerAnswers provides the latest information on the most effective traditionaland alternative multiple myeloma treatments available. multiple myeloma. http://www.canceranswers.com/Multiple.Myeloma.html

MULTIPLE MYELOMA What are "Plasma Cells"? Plasma cells are "B" lymphocytes in their final stage of development, when they are actually producing antibodies to fight "germs" like bacteria, viruses, fungi or protozoan parasites. They are an integral part of the immune system . There are basi-cally two types of immunity, called "cellular" and "humoral" immunity. Lymphocytes are white blood cell (about 30% of adult's while blood cells) that are actively involved in both types of immunity. "Cellular" immunity means that the white blood cells directly kill foreign invading germs, such as by enveloping and digesting them, while the "humoral" type means that the invaders are coated by antibodies and then gradually enveloped and digested by other white blood cells. The invading germs have markers on their cell surfaces, called "antigens" which tell the immune system that they are foreign to the body. The two common types of lymphocytes are "T" and "B" cells. "T" cells specialize in recognizing germs and activating the immune system, while "B" cells produce specific antibodies against the antigens that the "T" cells have recognized. The "B" cells go through a number of stages of development, and the final one is that they are specifically programmed to become antibody producing factories. The antibodies produced are specific to attack a particular kind of germ or foreign tissue. At this final stage of development, they are called

80. US Zometa — Multiple Myeloma multiple myeloma happens when healthy plasma cells become cancerous,and the bone marrow produces too many of these abnormal cells. http://www.us.zometa.com/info/cancerbones/myeloma.jsp

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 111    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20